Insmed Incorporated (NASDAQ: INSM), a development stage company, has comprehensive expertise in protein drug development. The company has a state-of-the art FDA-approved biologic commercial manufacturing facility in Boulder, Colorado and a corporate office in Richmond Virginia. By pursuing a dual path strategy, Insmed aims to advance its proprietary protein platform into niche markets with unmet needs while entering into the follow on biologics arena. For further information, visit the Company’s web site at www.insmed.com.
- 17 years ago
QualityStocks
Insmed Incorporated (NASDAQ: INSM)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Oncotelic Therapeutics Inc. (OTLC) Venture Begins Clinical Trials of Innovative Cancer Therapy
Oncotelic Therapeutics (OTCQB: OTLC) venture Sapu Nano recently secured approval from Australia’s Human Research Ethics Committee…
-
MAX Power Mining Corp. (CSE: MAXX) (OTC: MAXXF) Pioneers Natural Hydrogen Discovery to Fuel Clean Energy Future
This article has been disseminated on behalf of MAX Power Mining Corp. (CSE: MAXX) (OTC:…
-
Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Positions Itself in Platinum’s Next Chapter
Disseminated on behalf of Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) and may…